Track the GlucoTrack, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €3.3m. The latest transaction was reported on 7 October 2025 (Attribution). Among the most active insiders: Balo Andrew K. All data is free.
17
Insider Decl.
n/a
Thresholds
€215,880
1 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €215,880n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
182,539.6 shares@ US$1.26100.0% of flowCommon StockSEC:0001493152-24-015833:0
Canonical exit: 21 Jul 2024 (T+90)
17 of 17 declarations
About GlucoTrack, Inc.
GlucoTrack, Inc. is a company focused on developing blood glucose monitoring technologies. It specializes in non-invasive solutions for individuals with diabetes.